|
End-of-day quote
Taipei Exchange
06/10/2026
|
5-day change | 1st Jan Change | ||
| 199.00 TWD | +0.51% |
|
-8.51% | -23.46% |
| Fiscal Period: December | 2021 (TWD) | 2022 (TWD) | 2023 (TWD) | 2024 (TWD) | 2025 (TWD) |
|---|---|---|---|---|---|
Revenues | 1.24B | 1.96B | 1.4B | 1.47B | 1.83B |
Total Revenues | 1.24B | 1.96B | 1.4B | 1.47B | 1.83B |
Cost of Goods Sold, Total | 810M | 1.28B | 899M | 927M | 1.12B |
Gross Profit | 433M | 683M | 501M | 540M | 707M |
Selling General & Admin Expenses, Total | 108M | 146M | 133M | 169M | 199M |
Provision for Bad Debts | 369K | 356K | 147K | - | 445K |
R&D Expenses | 139M | 192M | 188M | 202M | 226M |
Other Operating Expenses, Total | 247M | 338M | 321M | 371M | 426M |
Operating Income | 185M | 345M | 180M | 169M | 281M |
Interest Expense, Total | -153K | -72K | -265K | -335K | -160K |
Interest And Investment Income | 2.66M | 13.85M | 26.79M | 32.13M | 21.62M |
Net Interest Expenses | 2.51M | 13.78M | 26.53M | 31.79M | 21.46M |
Currency Exchange Gains (Loss) | -4.4M | 45.2M | -10.11M | 39.59M | -24.31M |
Other Non Operating Income (Expenses) | 4.55M | 2.94M | 2.51M | 17.92M | 6.76M |
EBT, Excl. Unusual Items | 188M | 407M | 199M | 258M | 285M |
Asset Writedown | - | - | - | 390K | - |
EBT, Incl. Unusual Items | 188M | 407M | 199M | 259M | 285M |
Income Tax Expense | 31.68M | 72.38M | 29.66M | 52.15M | 56.98M |
Earnings From Continuing Operations | 156M | 335M | 169M | 207M | 228M |
Net Income to Company | 156M | 335M | 169M | 207M | 228M |
Net Income - (IS) | 156M | 335M | 169M | 207M | 228M |
Net Income to Common Incl Extra Items | 156M | 335M | 169M | 207M | 228M |
Net Income to Common Excl. Extra Items | 156M | 335M | 169M | 207M | 228M |
Per Share Items | |||||
Net EPS - Basic | 3.34 | 7.03 | 2.82 | 3.32 | 3.68 |
Basic EPS - Continuing Operations | 3.34 | 7.03 | 2.82 | 3.32 | 3.68 |
Basic Weighted Average Shares Outstanding | 46.84M | 47.67M | 60.01M | 62.25M | 62.03M |
Net EPS - Diluted | 3.27 | 6.77 | 2.77 | 3.25 | 3.67 |
Diluted EPS - Continuing Operations | 3.27 | 6.77 | 2.77 | 3.25 | 3.67 |
Diluted Weighted Average Shares Outstanding | 47.77M | 49.45M | 61.1M | 63.63M | 62.12M |
Normalized Basic EPS | 2.51 | 5.34 | 2.07 | 2.59 | 2.87 |
Normalized Diluted EPS | 2.46 | 5.15 | 2.03 | 2.54 | 2.87 |
Dividend Per Share | 1 | 3.85 | 2.5 | 2.95 | 2.95 |
Payout Ratio | 45.63 | 11.07 | 117.7 | 75.02 | 82.84 |
Supplemental Items | |||||
EBITDA | 191M | 351M | 184M | 173M | 286M |
EBITA | 185M | 345M | 180M | 169M | 281M |
EBIT | 185M | 345M | 180M | 169M | 281M |
EBITDAR | 192M | 352M | 186M | - | 290M |
Effective Tax Rate - (Ratio) | 16.84 | 17.77 | 14.92 | 20.15 | 20 |
Total Current Taxes | 27.08M | 81.49M | 50.39M | 52.93M | 54.51M |
Total Deferred Taxes | 4.6M | -9.11M | -20.73M | -781K | 2.47M |
Normalized Net Income | 118M | 255M | 124M | 162M | 178M |
Interest on Long-Term Debt | 153K | 72K | 265K | 335K | 160K |
Supplemental Operating Expense Items | |||||
Selling and Marketing Expenses | 59.54M | 90.23M | 84.54M | 106M | 122M |
General and Administrative Expenses | 48.02M | 55.62M | 48.95M | 63.01M | 76.78M |
Research And Development Expense From Footnotes | 139M | 192M | 188M | 202M | 226M |
Net Rental Expense, Total | 324K | 845K | 1.5M | - | 4.36M |
Imputed Operating Lease Interest Expense | - | 58.37K | 224K | - | 529K |
Imputed Operating Lease Depreciation | - | 787K | 1.27M | - | 3.83M |
Stock-Based Comp., Other (Total) | 1.3M | 2.55M | 8.56M | 3M | 18.08M |
Total Stock-Based Compensation | 1.3M | 2.55M | 8.56M | 3M | 18.08M |
Select your edition
All financial news and data tailored to specific country editions
















